Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pfizer and BioNTech announced the companies have agreed to a letter of intent regarding the co-development and distribution of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection.
read more
Wednesday, November 18, 2020
Pfizer and BioNTech have announced their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the study’s primary efficacy endpoints.
read more
Wednesday, December 02, 2020
Pfizer and BioNTech announced the MHRA in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine against COVID-19.
read more
Pfizer announced it will make a $465 million investment to build a sterile injectable pharmaceutical production facility in Portage, Michigan.
read more
Wednesday, August 24, 2016
Pfizer has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule anti-infectives business, primarily outside the United States.
read more
Wednesday, April 06, 2016
Pfizer has announced that the merger agreement between Pfizer and Allergan has been terminated by mutual agreement of the companies. The decision was driven by the actions announced by the U.S. Department of Treasury on April 4, 2016, which the ...
read more
Wednesday, April 20, 2016
Pfizer’s combined contract manufacturing organization, officially launches today. The multi-specialty CMO focuses on API synthesis and sterile injectables fill-finish.
read more
Pfizer has joined the TriNetX global health research network.
read more
Pfizer has expanded its research on vaccines to eventually safeguard people from cradle to grave, from shots for pregnant women to protect their babies from the moment of birth to vaccines for senior citizens with waning immune systems
read more
Tuesday, December 29, 2015
Pfizer Inc. today announced that it has completed its acquisition of Hospira, Inc.
read more
Pfizer has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net in cash (without interest but subject to ...
read more
Wednesday, March 07, 2018
Pfizer CentreOne announced the introduction of Enviero progesterone into the API marketplace.
read more
Friday, February 17, 2017
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, has expanded its fill-finish services to its Kalamazoo, Michigan (United States), site. Along with vial-filling of small molecules and biologics, the facility ...
read more
Wednesday, October 18, 2017
Pfizer CentreOne announced that it is now offering services in Nagoya, Japan.
read more
Pfizer CentreOne has grown its service portfolio to include contract manufacturing of highly potent solid oral dose medicines. The service will be provided at the Pfizer Newbridge, Ireland, facility, which is now part of Pfizer CentreOne’s contract ...
read more